Purple Biotech (PPBT) Income from Non-Controlling Interests (2021 - 2026)
Purple Biotech (PPBT) recorded Income from Non-Controlling Interests of $3,000 in Q1 2026, unchanged from $3,000 a year earlier and down 96.9% from the prior quarter.
Powered by 
Analysis
Purple Biotech (PPBT) Income from Non-Controlling Interests (2021 - 2026) Analysis & Trends
For FY2025, Purple Biotech reported Income from Non-Controlling Interests of $106,000, up 171.8% from FY2024.
- Annual Income from Non-Controlling Interests has a five-year compound annual growth rate of 7.2% (FY2020 to FY2025).
- Across earlier years, Income from Non-Controlling Interests came in at $39,000 in FY2024 (-59.8%), $97,000 in FY2023 (+5.4%), $92,000 in FY2022 (+9.5%) and $84,000 in FY2021 (+12.0%).
- Quarterly Income from Non-Controlling Interests has ranged from $2,000 in Q3 2025 to $97,000 in Q4 2025 over the past five years.
- Peak year-over-year performance for Income from Non-Controlling Interests in the last five years was growth of 108.3% in Q3 2022, against a decline of 84.2% in Q1 2025 at the low end.
- Per Business Quant, the preceding three quarters came in at $97,000 (Q4 2025), $2,000 (Q3 2025) and $4,000 (Q2 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Inc. Minority (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,076.25 Bn | 1,044.84 Bn | 19.71 Bn | - |
| 2 | Johnson & Johnson | 617.18 Bn | 535.70 Bn | 17.26 Bn | - |
| 3 | AbbVie | 464.58 Bn | 437.73 Bn | 12.70 Bn | 3.00 Mn |
| 4 | Merck | 356.04 Bn | 310.47 Bn | 12.21 Bn | -2.00 Mn |
| 5 | Novartis Ag | 269.07 Bn | 224.94 Bn | 11.24 Bn | -7.00 Mn |
| 6 | Astrazeneca | 243.21 Bn | 216.77 Bn | 12.86 Bn | 1.00 Mn |
| 7 | Amgen | 217.88 Bn | 173.28 Bn | 7.24 Bn | - |
| 8 | Gilead Sciences | 179.62 Bn | 153.74 Bn | 6.22 Bn | - |
| 9 | Pfizer | 158.45 Bn | 105.40 Bn | 10.94 Bn | 10.00 Mn |
| 10 | Purple Biotech | 247,575.07 | 189,575.07 | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Mar 31, 2026 | 3,000.00 |
| Dec 31, 2025 | 97,000.00 |
| Sep 30, 2025 | 2,000.00 |
| Jun 30, 2025 | 4,000.00 |
| Mar 31, 2025 | 3,000.00 |
| Dec 31, 2024 | 5,000.00 |
| Sep 30, 2024 | 5,000.00 |
| Jun 30, 2024 | 10,000.00 |
| Mar 31, 2024 | 19,000.00 |
| Dec 31, 2023 | 31,000.00 |
| Sep 30, 2023 | 19,000.00 |
| Jun 30, 2023 | 22,000.00 |
| Mar 31, 2023 | 25,000.00 |
| Dec 31, 2022 | 32,000.00 |
| Sep 30, 2022 | 25,000.00 |
| Jun 30, 2022 | 16,000.00 |
| Mar 31, 2022 | 19,000.00 |
| Dec 31, 2021 | 34,000.00 |
| Sep 30, 2021 | 12,000.00 |
| Jun 30, 2021 | 16,000.00 |
API Access
Purple Biotech Income from Non-Controlling Interests API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=income-from-non-controlling-interests&ticker=PPBT&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "income-from-non-controlling-interests", "ticker": "PPBT", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=income-from-non-controlling-interests&ticker=PPBT&period=max&api_key=YOUR_API_KEY");
const data = await res.json();